asa semaglutide Diagenic changes name to NEL following acquisition of NEL Hydrogen Holding AS Semaglutide Claim Eligibility for Injured

This is similar to whats reported in FDA data, which shows the most common side effect, nausea, happens in 44% of people on Wegovy (compared to 16% of people on a placebo)

40 GI side effects are most frequent and include nausea (25-44%), diarrhea (19-30%), vomiting (8-24%), constipation (17-24%), and abdominal pain (9-20%)

Please consult a healthcare professional before using any dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.

Compared to subcutaneous injection, oral administration represents a novel option that can enhance patient acceptance and adherence